Assessment of the Neurosensory Alteration After Inferior Alveolar Nerve Lateralization

Assessment of the Neurosensory Alteration With Computer Guided Inferior Alveolar Nerve Lateralization Versus Non Guided Classic Technique

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03669510

Enrollment

Registered

2018-09-13

Start date

2019-01-01

Completion date

2020-03-20

Last updated

2024-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Implant Site Reaction

Brief summary

: Assessment of the neurosensory alteration with computer guided inferior alveolar nerve lateralization versus non guided classic technique and measuring stability of implant after placement

Interventions

OTHERcomputer guided IAN lateralization surgical technique

Tthe neurosensory alterations with computer guided inferior alveolar nerve lateralization versus non guided classic technique

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

SINGLE (Outcomes Assessor)

Intervention model description

atrophic posterior mandible requiring nerve lateralization

Eligibility

Sex/Gender

ALL

Healthy volunteers

Yes

Inclusion criteria

* Adult patients with with atrophied posterior mandibular ridge * both sexes * NO intra oral soft and hard tissue pathology * NO systematic that contraindicate implant placement

Exclusion criteria

* Presence pathological lesion * Heavy smokers more than 20 cigarettes per day. * patients with systemic disease that may affect normal healing

Design outcomes

Primary

Measure	Time frame	Description
Assessment of the neurosensory alteration- sensation over time subjective(a scale 1-10)	1 year	assessing the sensation regaining over time subjective (a scale 1-10 )

Secondary

Measure	Time frame	Description
Implant stability	At the placement and after exposure ( up to 6 months )	Measurements of the implant stability immediately after placement by osstell

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026